We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -1.78% | 33.10 | 32.95 | 33.85 | 33.95 | 32.95 | 33.95 | 1,864,058 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 195.88 | 179.87M |
TIDMAPH
RNS Number : 6283L
Alliance Pharma PLC
12 January 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES --------------------------------------------------------------------------------------- 1. Identity of the issuer or ALLIANCE PHARMA the underlying issuer of existing shares to which voting rights are attached: --------------------------------------------------------- ---------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------- An acquisition or disposal of voting rights Yes ---------------------------------------------------------- --------------------------- An acquisition or disposal of qualifying financial No instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------- --------------------------- An acquisition or disposal of instruments with No similar economic effect to qualifying financial instruments ---------------------------------------------------------- --------------------------- An event changing the breakdown of voting rights No ---------------------------------------------------------- --------------------------- Other (please NA specify): -------------------------------------------------------- --------------------------- 3. Full name of person(s) River and Mercantile Asset subject to the Management LLP notification obligation: --------------------------------------------------------- ---------------------------- 4. Full name of shareholder(s) (if different from 3.): --------------------------------------------------------- ---------------------------- 5. Date of the transaction 17/12/2015 and date on which the threshold is crossed or reached: --------------------------------------------------------- ---------------------------- 6. Date on which issuer 17/12/2015 notified: --------------------------------------------------------- ---------------------------- 7. Threshold(s) that is/are crossed or reached: 5% --------------------------------------------------------- ---------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares ------------------------------------------------------------------------------------------------------------------------ Class/type Situation Resulting situation after the of previous triggering transaction shares to the triggering transaction if possible using the ISIN CODE --------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights ------------- --------------- --------------- ------------- --------------------------- ------------------------- Direct Direct Indirect Direct Indirect ------------- ----------- ----------- ------------- ------------- ------------ ------------ ----------- GB0031030819 0 0. 00% 24,000,000 24,000,000 NA 5.12% NA --------------- --------------- ------------- ------------- ------------ ------------ ----------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument Period may be acquired if the instrument is exercised/ converted. ----------------- --------------- ------------------------------ ----------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------------------ Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights instrument period refers to ------------- --------------- --------------- --------------- ----------------------------- ----------------------- Nominal Delta ------------- --------------- --------------- --------------- ----------------------------- ------------ --------- Total (A+B+C) ------------------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights --------------------------------------------------- ------------------------------------------------------------------- 24,000,000 5.12% --------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: --------------------------------------------------------------- Proxy Voting: --------------------------------------------------------------- 10. Name of the proxy holder: River and Mercantile Asset Management LLP --------------------------------------- ---------------------- 11. Number of voting rights proxy NA holder will cease to hold: --------------------------------------- ---------------------- 12. Date on which proxy holder will NA cease to hold voting rights: --------------------------------------- ---------------------- 13. Additional information: --------------------------------------- ---------------------- 14. Contact name: Hamish Byrne --------------------------------------- ---------------------- 15. Contact telephone number: +44 (0) 20 7601 6262 --------------------------------------- ----------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEALFAFDAKEFF
(END) Dow Jones Newswires
January 12, 2016 09:34 ET (14:34 GMT)
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions